Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 063183/0507 | |
| Pages: | 11 |
| | Recorded: | 03/31/2023 | | |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
12
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
14391929
|
Filing Dt:
|
10/10/2014
|
|
Publication #:
|
|
Pub Dt:
|
03/12/2015
| | | | |
|
Title:
|
NOVEL CHOLESTEROL METABOLITE, 5-CHOLESTEN, 3BETA-25-DIOL, DISULFATE (25HCDS) FOR THERAPY OF METABOLIC DISORDERS, HYPERLIPIDEMIA, DIABETES, FATTY LIVERS DISEASES AND ATHEROSCLEROSIS
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
15241171
|
Filing Dt:
|
08/19/2016
|
|
Publication #:
|
|
Pub Dt:
|
12/08/2016
| | | | |
|
Title:
|
NOVEL CHOLESTEROL METABOLITE, 5-CHOLESTEN, 3BETA-25-DIOL, DISULFATE (25HCDS) FOR THERAPY OF METABOLIC DISORDERS, HYPERLIPIDEMIA, DIABETES, FATTY LIVERS DISEASES AND ATHEROSCLEROSIS
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
15517395
|
Filing Dt:
|
04/06/2017
|
|
Publication #:
|
|
Pub Dt:
|
09/07/2017
| | | | |
|
Title:
|
OXYGENATED CHOLESTEROL SULFATES FOR THERAPY OF DISORDERS CAUSED BY AT LEAST ONE OF ATTENUATED LEPTIN ACTIVITY AND A LIPID STORAGE DISORDER
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
15728827
|
Filing Dt:
|
10/10/2017
|
|
Publication #:
|
|
Pub Dt:
|
05/10/2018
| | | | |
|
Title:
|
NOVEL CHOLESTEROL METABOLITE, 5-CHOLESTEN, 3BETA-25-DIOL, DISULFATE (25HCDS) FOR THERAPY OF METABOLIC DISORDERS, HYPERLIPIDEMIA, DIABETES, FATTY LIVERS DISEASES AND ATHEROSCLEROSIS
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16108286
|
Filing Dt:
|
08/22/2018
|
|
Publication #:
|
|
Pub Dt:
|
03/21/2019
| | | | |
|
Title:
|
OXYGENATED CHOLESTEROL SULFATES FOR THERAPY OF DISORDERS CAUSED BY AT LEAST ONE OF ATTENUATED LEPTIN ACTIVITY AND A LIPID STORAGE DISORDER
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16140964
|
Filing Dt:
|
09/25/2018
|
|
Publication #:
|
|
Pub Dt:
|
05/09/2019
| | | | |
|
Title:
|
CHOLESTEROL METABOLITE, 5-CHOLESTEN, 3BETA-25-DIOL, DISULFATE (25HCDS) FOR THERAPY OF METABOLIC DISORDERS, HYPERLIPIDEMIA, DIABETES, FATTY LIVERS DISEASES AND ATHEROSCLEROSIS
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16320400
|
Filing Dt:
|
01/24/2019
|
|
Publication #:
|
|
Pub Dt:
|
12/12/2019
| | | | |
|
Title:
|
USE OF OXYGENATED CHOLESTEROL SULFATES (OCS) TO TREAT INFLAMMATORY SKIN DISEASE AND SKIN LESIONS
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16593460
|
Filing Dt:
|
10/04/2019
|
|
Publication #:
|
|
Pub Dt:
|
05/07/2020
| | | | |
|
Title:
|
OXYGENATED CHOLESTEROL SULFATES FOR THERAPY OF DISORDERS CAUSED BY AT LEAST ONE OF ATTENUATED LEPTIN ACTIVITY AND A LIPID STORAGE DISORDER
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16599044
|
Filing Dt:
|
10/10/2019
|
|
Publication #:
|
|
Pub Dt:
|
05/21/2020
| | | | |
|
Title:
|
NOVEL CHOLESTEROL METABOLITE, 5-CHOLESTEN, 3BETA-25-DIOL, DISULFATE (25HCDS) FOR THERAPY OF METABOLIC DISORDERS, HYPERLIPIDEMIA, DIABETES, FATTY LIVERS DISEASES AND ATHEROSCLEROSIS
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17072994
|
Filing Dt:
|
10/16/2020
|
|
Publication #:
|
|
Pub Dt:
|
06/10/2021
| | | | |
|
Title:
|
USE OF OXYGENATED CHOLESTEROL SULFATES (OCS) TO TREAT INFLAMMATORY SKIN DISEASE AND SKIN LESIONS
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17087364
|
Filing Dt:
|
11/02/2020
|
|
Publication #:
|
|
Pub Dt:
|
06/03/2021
| | | | |
|
Title:
|
OXYGENATED CHOLESTEROL SULFATES FOR THERAPY OF DISORDERS CAUSED BY AT LEAST ONE OF ATTENUATED LEPTIN ACTIVITY AND A LIPID STORAGE DISORDER
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17122647
|
Filing Dt:
|
12/15/2020
|
|
Publication #:
|
|
Pub Dt:
|
08/05/2021
| | | | |
|
Title:
|
CHOLESTEROL METABOLITE, 5-CHOLESTEN, 3BETA-25-DIOL, DISULFATE (25HCDS) FOR THERAPY OF METABOLIC DISORDERS, HYPERLIPIDEMIA, DIABETES, FATTY LIVERS DISEASES AND ATHEROSCLEROSIS
|
|
|
Assignees
|
|
|
|
|
| 800 EAST LEIGH STREET, SUITE 3000 |
| RICHMOND, VIRGINIA 23298 |
|
|
|
|
|
| 810 VERMONT AVENUE, N.W. |
| OFFICE OF GENERAL COUNSEL |
| WASHINGTON, DISTRICT OF COLUMBIA 20420 |
|
|
Correspondence name and address
|
| |
DURECT CORPORATION
|
| |
10260 BUBB ROAD
|
| |
CUPERTINO, CA 95014
|
Search Results as of:
09/26/2024 05:49 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
